UB-211

N/A

Report date: 2024/04/15 16:15:45

Base Information

Drug NameUB-211
Drug Alias NameUB-211
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionImmunoglobulin E inhibitors
TargetsImmunoglobulin E
Therapy Area/IndicationsHypersensitivityRhinitis, Allergic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUnited Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesUnited Biopharma Inc
Inactive CompaniesN/A
Active IndicationsHypersensitivityRhinitis, Allergic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A